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Expression of renal aquaporins 1, 2, and 3 in a rat model of To date, at least 11 different types of AQPs have been
cisplatin-induced polyuria. cloned and characterized. Of these, the expression and/or
Background. Cisplatin (CP)-induced polyuria in rats is at- physiological regulation of AQP1, AQP2, AQP3, AQP4,tributed to decreased medullary hypertonicity and/or an end-
and AQP6 are well documented in the kidney [1, 2].organ resistance to vasopressin. However, the roles of renal
AQP1 is constitutively and very abundantly expressedaquaporins (AQPs) have not yet been explored.
Methods. Male Sprague-Dawley rats (230 to 245 g) received on both the apical and basolateral domains of proximal
either a single injection of CP (5 mg/kg, N 5 4) or saline (N 5 4) tubular cells and the cells of the descending limb of
intraperitoneally five days before sacrifice. Urine, blood, and Henle’s loop. In this part of the proximal nephron, AQP1kidney samples were analyzed.
aids the rapid reabsorption of large quantities (70 toResults. Platinum accumulated in the cortex and outer me-
80%) of filtered water isosmotically coupled to the trans-dulla of CP-treated rats (39.05 6 7.50 and 36.48 6 12.44 mg/g
vs. 2.52 6 0.43 and 1.87 6 0.84 mg/g dry tissue in controls, port of sodium. AQP1 is also expressed in the renal
respectively). Histologically, tubular damage and decreased microvasculature, especially the medullary descending
AQP1 immunolabeling were detected in the S3 segment of
vasa recta, which takes part in the counter current multi-proximal tubules. CP treatment caused 4.4- and 4.8-fold in-
plication mechanism and thus plays an important role increases, respectively, in blood urea nitrogen and urine volume,
and a 4.4-fold decrease in urine osmolality. Immunoblots the urinary concentrating mechanism [3]. AQP2, AQP3,
showed that AQP2 and AQP3 were significantly reduced to and AQP4 are expressed in the collecting duct principal
33 6 10% (P , 0.001) and 69 6 11% (P , 0.05), respectively, cells and aid in the osmotic transport of water in this
in the inner medulla of CP-treated rats. Immunocytochemical
part, which accounts for the reabsorption of 10 to 20%analysis showed a decrease in AQP2 labeling in the inner
of filtered water. However, the absorption of this smallmedulla of CP-treated rats. Northern hybridization revealed a
33 6 11% (P , 0.002) decrease in AQP2 mRNA expression in fraction of free water, which is under the control of
the inner medulla of CP-treated rats. AQP1 protein expression arginine vasopressin (AVP), determines the osmolality
levels were modestly (67 6 7%, P 5 0.057) and significantly of the final voided urine. AQP3 is expressed on the
(53 6 13%, P , 0.007) decreased in outer and inner medullae,
basolateral aspect of the principal cells throughout therespectively, of CP-treated rats.
collecting duct. AQP4 is also expressed on the basolat-Conclusions. CP-induced polyuria in rats is associated with
eral aspects of the same cells, but is restricted to thea significant decrease in the expression of collecting duct
(AQP2 and AQP3) and proximal nephron and microvascular distal third of the medullary collecting ducts. On the
(AQP1) water channels in the inner medulla. other hand, AQP2 is expressed only on the apical domain
and also on the subapical vesicles of collecting duct prin-
cipal cells, and is regulated by AVP via the V2 subtype
Aquaporins (AQPs) are members of a family of mem- of vasopressin receptor that is coupled to the cAMP
brane channels that allow rapid movement of water across second-messenger system. Vasopressin has both short-
permeable epithelia, such as renal tubular epithelium. and long-term effects on the expression of AQP2 [4].
The short-term effect (within a few minutes) consists
of the translocation of AQP2 water channel-containingKey words: collecting duct, nephrotoxicity, vasopressin, proximal tu-
bules, medullary hypertonicity. subapical vesicles to the apical plasma membrane. The
long-term effect (several hours to few days) promotesReceived for publication October 27, 1999
the synthesis of AQP2 mRNA, resulting in an increaseand in revised form January 13, 2000
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distributed in intracellular vesicles in multiple types of METHODS
renal epithelia, where it apparently participates in dis- Animals and treatment
tinct physiological functions such as glomerular filtration, Male Sprague-Dawley rats (Harlan Sprague-Dawley,
tubular endocytosis, and acid-base metabolism [2]. Re- Indianapolis, IN, USA) weighing 230 to 245 g were used
cent studies on animal models of several clinically rele- in this study. The rats were housed two per cage and
vant acquired polyuric conditions, such as lithium- or were maintained on a 12-hour light/dark cycle and had
hypokalemia-induced bilateral ureteral obstruction, hy- free access to drinking water and standard rat chow. The
percalcemia, and ischemic reperfusion injury, revealed animals were acclimated to the housing conditions for a
that these pathophysiological conditions are associated few days prior to the experimental procedures. Baseline
with a significant reduction in the expression levels of urine samples were collected over a period of 24 hours
collecting duct water channels [5, 6]. prior to treatment (day 0) by placing the animals in
Cisplatin (CP; cis-dichlorodiammine platinum II) is a individual metabolic cages. On day 1, the rats were di-
potent antineoplastic agent in which the clinical use is vided into two groups (N 5 4 per group) and were in-
limited because of its potential renal toxicity leading to jected intraperitoneally with either 5 mg/kg body wt CP
acute renal failure [7–9]. CP also induces dose-related (Alfa Products, Ward Hill, MA, USA) in a volume of
nephrotoxicity in laboratory animals. The nephrotoxicity 0.5 to 0.6 mL normal saline (CP-treated group) or with
manifests as a reduction in glomerular filtration rate [ele- an equal volume of normal saline alone (control group).
vation in blood urea nitrogen (BUN) and serum creatinine On day 4, the animals were placed in metabolic cages
levels], polyuria, a marked defect in urine concentrating to collect a second 24-hour urine sample. Rats were
ability, proteinuria, hyperuricemia, and frequently, mag- euthanized on day 5 by sodium pentobarbital overdose,
nesium wasting [10]. Pathologically, toxicity in both hu- and whole blood was collected by cardiac puncture while
mans and laboratory animals is characterized by damage the animals were in deep anesthesia. Both kidneys were
to the S3 segment (pars recta) of the proximal tubule quickly removed, placed in ice-cold sterile phosphate-
[11–15]. In addition, while the human kidneys show evi- buffered saline (PBS) in Petri dishes, and decapsulated.
dence of necrosis of the distal tubules and collecting One kidney was transversely bisected, and one half was
ducts [16, 17], there is controversy with respect to the immersed in neutral-buffered 10% formalin for fixation
effect of CP on the distal tubules of rodent kidneys, with for immunohistochemical studies. Cortex and outer and
reports ranging from no damage [18, 19] to moderate or inner medullae were dissected from the remaining one-
to severe damage [13]. and-one-half kidneys and flash frozen in liquid nitrogen
The most prominent feature of CP nephrotoxicity is before storing at 2758C. The sharp dissection of different
polyuria, which occurs in two distinctive phases. Early regions of rat kidneys was performed on ice and under
polyuria occurs when the glomerular filtration rate (GFR) a dissection microscope. Each kidney was cut across into
is still normal (1 to 2 days following a single dose) and four to five pieces and kept in ice-cold PBS. From each
can be reversed by the administration of vasopressin, sug- piece, the cortical tissue was excised from the rest of the
gesting impaired release of this hormone from the pitu- medulla using the differential coloration of corticomed-
itary gland [10, 20]. The late-phase polyuria, which occurs ullary junction as a landmark. Then the reddish outer
when the GFR is low (5 to 6 days following a single medulla, including the outer and inner stripes, was sepa-
dose), is of renal origin, and is resistant to vasopressin rated from the white papillary portion or inner medulla
administration. This end-organ resistance to vasopressin of the kidney.
is associated with a decrease in papillary hypertonicity
Analysis of blood and urine samples[19, 21] and reduced cAMP generation, secondary, in
part or whole, to a defect in the G-protein–mediated Blood urea nitrogen concentration was determined
signaling in the collecting ducts [22]. The regulation of colorimetrically using a commercially available kit (Sigma
collecting duct water permeability by vasopressin is me- Chemical Co., St. Louis, MO, USA). Twenty-four–hour
diated by its effect on the translocation and/or expression urine volumes were measured. Aliquots of urine samples
of AQP2 water channel, which involves an intact cAMP were centrifuged at 10,000 3 g for five minutes to remove
second-messenger system. Hence, we hypothesized that suspended material, if any, and the supernatants were
the late polyuria induced by CP is associated with the used to measure the osmolality by freezing point depres-
decreased expression of collecting duct water channels. sion using a Microosmometer Model 3300 (Advanced
In the current study, we examined that hypothesis by Instruments Inc., Norwood, MA, USA).
determining the expression levels of collecting duct water
Assay of tissue platinum levelschannels (AQP2 and AQP3) and the proximal nephron
water channel (AQP1) in a rat model of CP-induced Platinum levels in the renal cortex and outer medulla
were assayed as described previously [23]. Briefly, tissuepolyuria.
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samples (about 150 mg wet wt) were oven dried to con- The cDNA probe for b-actin was generated by PCR
amplification of rat kidney cDNA using the primers asstant weight at 708C and reweighed (dry wt). Dried tissue
samples were then digested in nitric acid, and platinum previously described [27].
levels in the digest were determined by flameless atomic
Extraction of total RNA and Northern hybridizationabsorption spectroscopy using a Perkin-Elmer Model
380 Spectrophotometer fitted with a model HGA 400 These were carried out essentially as described pre-
viously [28]. Briefly, total RNA was extracted from theprogrammer. A calibration curve was constructed by
using appropriate nitric acid dilutions of a commercially inner medullary tissue using Tri-Reagent (Molecular Re-
search Center, Inc., Cincinnati, OH, USA) as per theavailable platinum atomic absorption spectroscopy stan-
dard solution (Sigma Chemical Co.). Results are ex- manufacturer’s protocol. Twenty micrograms of total
RNA from each sample were chemically and heat dena-pressed as micrograms of platinum per gram dry tissue.
tured and size fractionated on an 1% formalin agarose
Polyclonal antibodies and cDNA probes for the gel in 1 3 MOPS buffer for 4.5 hours at 96 V. Equality
detection of AQPs of sample loading was determined by matching the den-
sity of the 28S rRNA band visualized by ethidium bro-Peptide-derived, affinity-purified polyclonal antibodies
to AQPs 1, 2, and 3 were used in this study. The antibod- mide staining. RNA was transferred to Hybond N1 ny-
lon membrane overnight by capillary transfer methodies to AQP1 (L266) and AQP3 (L178) were kindly sup-
plied by Dr. Mark Knepper (NHLBI, NIH, Bethesda, using 10 3 standard saline citrate (SSC) buffer and then
ultraviolet cross-linked. The total RNA blot was prehy-MD, USA) and have been characterized previously
[24, 25]. The antibody to AQP2 (GN-762) was commer- bridized in 15 mL ExpressHyb (Clontech Laboratories,
Palo Alto, CA, USA) for 30 minutes at 688C and thencially raised (Genosys Biotechnologies, Inc., The Wood-
lands, TX, USA) by using standard methods against a hybridized with 1.5 3 106 cpm/mL of 32P random-labeled
(High Prime DNA Label; Boehringer-Mannheim, India-C-terminal peptide sequence designed and published by
Dr. Knepper [26]. GN-762 was purified and character- napolis, IN, USA) rat cDNA probe for AQP2 for two
hours at 688C. Membranes were washed two times atized by us as follows. The antiserum was affinity purified
using a column of agarose beads on which the immunizing room temperature for 15 minutes each in 2 3 SSC, 0.05%
sodium dodecyl sulfate (SDS), and two times at 508C forpeptide was immobilized via a covalent linkage (Sulfo-
Link Immobilization Kit # 2; Pierce, Rockford, IL, USA). 15 minutes each in 0.1 3 SSC, 0.1% SDS and exposed
to x-ray film (MS Film; Eastman Kodak Co., New Haven,An IgG fraction of the GN-762 preimmune serum was
prepared on a protein A column (Pierce) for use in control CT, USA) overnight at 2708C with a Kodak-intensifying
screen. The membranes were striped by boiling in 0.5%experiments. Control immunoblots were prepared by
using crude membrane fractions of rat kidney inner me- SDS for 30 minutes and then probed with a 32P-labeled
cDNA probe for b-actin as a control for loading.dulla as a source of AQP2 protein and were probed with
either the affinity-purified antibody alone or affinity-
Preparation of membrane vesicle fractionspurified antibody preadsorbed with an excess of immu-
and immunoblottingnizing peptide or with the purified preimmune IgG frac-
tion at similar concentrations. The blots probed with Fractions enriched in both plasma membranes and
intracellular vesicles were prepared as described pre-the affinity-purified AQP2 antibody gave two bands that
correspond to the expected molecular mass of the native viously [28, 29] with a few modifications. Briefly, tissue
samples were homogenized in isolation solution con-and glycosylated AQP2 protein. Both of these bands
were ablated by the preadsorption of the antibody by taining protease inhibitors using polytron tissue homoge-
nizer. The homogenates were initially spun at 1000 3 gthe immunizing peptide. No bands could be seen when
the preimmune IgG fraction was used to probe the blots for 10 minutes at 48C to pellet nuclei and cell debris.
Then the supernatants were centrifuged at 150,000 3 g(data not shown here). In our immunohistochemical stud-
ies, we also used another AQP1 antibody (4835-EXT1; for 90 minutes at 48C in a Beckman ultracentrifuge to
pellet both plasma membrane and intracellular vesicles.Zymed Laboratories, Inc., South San Francisco, CA,
USA) that we commercially raised using the same pep- The pellets were suspended in isolation solution with
protease inhibitors, and the total protein concentrationtide sequence that Dr. Knepper used for raising L266.
This AQP1 antibody was purified and characterized pre- was measured. The membrane vesicle fractions thus pre-
pared were solubilized at 608C for 20 minutes in Laemmliviously [27]. The cDNA probe for AQP2 was obtained
from a polymerase chain reaction (PCR) amplification sample buffer. The solubilized membrane proteins were
electrophoresed on 12% polyacrylamide minigels (No-of rat cDNA using rat AQP2 sequence-specific primers.
The 370 bp amplification product was subcloned and vex, San Diego, CA, USA) under denaturing conditions.
Equality of protein loading was checked by running load-sequence confirmed. The product extends from nt 281
to 651 of the mRNA (GenBank accession no. D13906). ing gels and staining the separated proteins by Coomassie
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blue. The size-fractionated proteins were electrophoreti- dine for four minutes and counterstained with 0.1% nu-
clear fast red in 5% aluminum sulfate. Labeling controlscally transferred to nitrocellulose membranes (Novex)
using Bio-Rad transfer apparatus (Bio-Rad Laboratories, were performed under the same conditions but by omit-
ting either the primary or the secondary antibody, orHercules, CA, USA). The membranes were blocked with
milk proteins and then probed with affinity-purified poly- using preimmune IgG (0.5 mg/mL) in place of primary
antibody as described previously in this article. The sec-clonal antibodies to AQP1 (L266) or AQP2 (GN-762)
or AQP3 (L178) at an IgG concentration of 0.03 to tions were examined by at least two investigators, of
which one was blind to the CP treatment status. How-0.14 mg/mL. After washing to remove the nonspecifically
bound primary antibodies, the membranes were probed ever, the differences between the control and CP-treated
groups are so striking that a cursory examination underwith donkey antirabbit IgG conjugated to horseradish
peroxidase (Pierce number 31458) at an IgG concentra- light microscope readily distinguishes these groups, as
differences in both staining pattern and cellular and tu-tion of 0.16 mg/mL. Membranes were washed again, and
the sites of antigen-antibody reaction were visualized by bular architecture are obvious. Digital microphoto-
graphs were taken with a Nikon Coolpix 950 digital cam-chemiluminescence (SuperSignal Substrate; Pierce). The
reaction was captured on light-sensitive imaging film era mounted on a Nikon X-FL microscope.
(Kodak no. 165-1579 Scientific Imaging Film). Each im-
Statistical analysismunoblot was run at least twice to confirm the consis-
tency of results obtained. All quantitative data are expressed as mean 6 SEM.
Differences among the means of multiple parameters
Quantitation of mRNA and protein levels were analyzed by one-way analysis of variance (ANOVA)
followed by Tukey–Kramer Multiple Comparisons test.Images obtained from both Northern and Western blot-
ting were scanned on a flatbed scanner (Plustek, OptiPro Differences between two parameters were analyzed by
either unpaired t-test or by nonparametric methods483P), and the density of the bands was quantitated using
ImageQuant software (Molecular Dynamics, Sunnyvale, (Mann–Whitney test). P values of less than 0.05 were
considered significant. Instat2 software (GraphPad Soft-CA, USA). Densitometry results are reported as volume
integrated values expressed as percentage of the mean ware Inc., San Diego, CA, USA) was used for all statisti-
cal analysis.values in controls (100%). For Northern hybridization,
the band densities of AQP2 were normalized by the corre-
sponding band densities of b-actin and were expressed as
RESULTS
percentage of the mean values in controls (100%).
Body weight
Histology and immunohistochemistry Table 1 presents the body weights in control and CP-
treated groups of rats. Five days after initiation of theKidney samples were fixed in neutral-buffered 10%
formalin for two days at room temperature, transferred experiment, the control group showed a significant
(11%) increase in body weight (P , 0.001), whereas theto methanol, and then embedded in paraffin. Sections
(5 mm thickness) were cut on a microtome and processed CP-treated groups has a significant loss (5.2%) of initial
body weight (P , 0.05). Since the initial body weightsfor immunocytochemical labeling as described previously
[27]. Paraffin sections were stained with hematoxylin in both groups on day 0 were similar, it is reasonable to
assume that the CP-treated group showed a net loss ofand eosin for conventional histologic examination. For
immunocytochemical labeling, tissue sections were de- 16% in their body weight on day 5 as compared with
the control group, indicating a generalized debilitatingparaffinized in xylene and rehydrated through a series
of graded ethanol. Endogenous peroxidase activity was condition.
removed by incubating with hydrogen peroxidase. Non-
Urine analysisspecific binding was blocked by incubation of sections
with normal goat serum. Sections were then incubated Table 1 shows urine volumes and osmolality at the
initiation (day 0) and completion (day 5) of the study.with either AQP1 antibody (4835 EXT1; 0.4 mg/mL) or
AQP2 antibody (GN 762; 0.07 mg/mL) overnight at 48C. The urine volumes over a period of 24 hours were not
significantly different in control group on day 0 versusSections were rinsed five times in 0.1 mol/L PBS con-
taining 0.2% Triton X-100 and then incubated for one day 5. However, those collected from the CP-treated
group showed a 4.8-fold increase on day 5 as comparedhour at room temperature with biotinylated goat antirab-
bit antibody (Vector Labs, Burlingame, CA, USA), fol- with day 0, indicating severe polyuria. The urine osmol-
ality in the control group showed variability from day 0lowed by incubation with avidin-biotin complex (Vector
Labs) for one hour at room temperature. Sections were to day 5, but the mean values on both days are within
the normal physiological range. In contrast, the urinethen washed with PBS, rinsed briefly in 0.1 mol/L acetate
buffer, pH 6.0, and then incubated with diaminebenzi- osmolality in CP-treated rats showed a 4.4-fold decrease
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Table 1. Body weight, urine volume, urine osmolality, blood urea nitrogen (BUN) and tissue platinum
levels in control and cisplatin (CP)-treated rats
Controls CP-treated
Parameter Day 0 Day 5 Day 0 Day 5
Body weighta 100.061.7 111.0b 61.2 100.861.5 94.8c 61.7
Urine volume mL/24 h 14.860.9 11.960.7 10.361.8 49.8b 65.5
Urine osmolality mOsm/kg H2O 1313644 1686643 17836123 408d 639
BUN mg/dL — 17.2160.39 — 75.22e 611.73
Platinum in cortex lg/g dry tissue — 2.5260.43 — 39.05e 67.5
Platinum in outer med. lg/g dry tissue — 1.8860.84 — 36.48612.44
All values are mean 6 SEM, N 5 4 per group.
a As percentage of values in controls on day 0, where 100% is equivalent to 235 g
b P , 0.001 vs. corresponding day 0 values
c P , 0.05 vs. corresponding day 0 values and P , 0.001 vs. day 5 values in controls
d P , 0.001 vs. day 0 values in CP-treated group or day 5 values in controls
e P , 0.003 vs. control values
on day 5 as compared with the values in the same group tive and glycosylated AQP1 protein bands were signifi-
cantly decreased in the inner medulla. Figures 2 and 4on day 0, thus indicating a severe impairment of urinary
concentrating ability. document the changes in the expression levels of vaso-
pressin-regulated apical AQP2 protein of collecting ducts
Blood urea nitrogen and tissue platinum levels in the cortex and outer and inner medullae. In the cortex,
the expression of the native band showed a modest de-Table 1 shows the BUN and tissue platinum levels at
the end of the study (day 5). The BUN values in CP- crease with borderline significance (42 6 25%, P 5
0.051), while the glycosylated band was not altered (P 5treated rats are 4.4-fold higher as compared with the
values in control group, indicating severe renal func- 0.24). In the outer medulla, both the native and glycosy-
lated bands showed modest nonsignificant decreases.tional impairment in CP-treated animals. The mean
background levels of platinum in the cortex and outer However, the levels or abundance of native and glycosy-
lated AQP2 protein expressed in the inner medulla weremedulla of control animals by our assay method were
2.52 6 0.43 and 1.88 6 36.49 mg/g dry tissue. Thus, the significantly decreased (42 6 7%, P , 0.004, and 29 6
12%, P , 0.001). Figures 3 and 4 document the changesmean platinum levels in the renal cortex and outer me-
dulla of the CP-treated rats were 15- and 19-fold higher in the expression levels of AQP3. In the cortex and outer
medulla of CP-treated rats, the AQP3 water channelthan the respective control values, indicating that the
renal cortex and outer medulla of these rats accumulated showed a modest, but statistically nonsignificant increase
in both native and glycosylated protein bands. However,large amounts of the injected drug. Furthermore, there
is a significant correlation between levels of platinum in CP treatment significantly decreased the expression of
native (69 6 11%, P , 0.05) and glycosylated (69 6the cortex and outer medulla (r 5 0.93, P , 0.04). For
want of sufficient sample size, we could not assay the 10%, P , 0.03) AQP3 protein in the inner medulla.
platinum levels in the inner medulla of these animals.
Northern hybridization
Immunoblotting studies To determine whether the changes in the expression
levels of AQP2, the vasopressin-regulated apical waterA semiquantitative immunoblotting approach was used
to examine the effect of CP treatment on the expression channel protein, were accompanied by corresponding
changes in the expression levels of AQP2 mRNA levels,levels of AQP proteins in different regions of the kidney.
Figures 1–3 show the expression of both native (26 to we performed Northern analysis on total RNA from the
inner medulla using a gene-specific cDNA probe for29 kD) and glycosylated (33 to 55 kD) protein bands of
AQP1 (Fig. 1), AQP2 (Fig. 2), and AQP3 (Fig. 3). Figure 4 AQP2. The same membrane was probed with a gene-
specific probe for b-actin as an internal control. Figurerepresents the percentage changes in protein expression
levels quantitated either individually (native or glycosy- 5 shows the expression levels of AQP2 mRNA normal-
ized to b-actin mRNA levels. In the CP-treated rats,lated) or combined together (total) in CP-treated group
as compared with the control group. As seen in Figures AQP2 mRNA levels were significantly decreased to 33 6
11% of the control values (P , 0.002).1 and 4, the abundance or levels of AQP1 protein expres-
sion was not altered in the cortex (P 5 0.68), while
Histologic examinationits total amount was decreased to a modest value with
borderline significance (67 6 7%, P 5 0.057) in the outer Conventional histologic examination using light mi-
croscopy on paraffin sections of kidney stained with he-medulla. However, the expression levels of both the na-
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Fig. 2. Representative immunoblots of AQP2 water channel in cortex
and outer and inner medullae of saline-treated (controls) and CP-
treated rats. Quantities of 10, 5, and 1.5 mg of total protein were loadedFig. 1. Representative immunoblots of aquaporin 1 (AQP1) water
in each lane of the gel for cortex, outer, and inner medullae, respectively.channel in cortex and outer and inner medullae of saline-treated (con-
Blots were probed with AQP2 antibody (GN-762) at an IgG concentra-trols) and cisplatin (CP)-treated rats. Quantities of 1.5, 1.5, and 5 mg
tion of 0.14 mg/mL. Blots were exposed to longer duration to visualizeof total protein were loaded in each lane of the gel for cortex, outer, and
the bands from all the lanes.inner medullae, respectively. Blots were probed with AQP1 antibody
(L226) at an IgG concentration of 0.04 mg/mL. Blots were exposed for
longer duration to visualize the glycosylated protein bands.
outer or inner medulla at the magnifications we could
achieve with the light microscope.
matoxylin-eosin showed striking and consistent differ-
Immunocytochemical examinationences between the CP-treated group and the control
group in the deep cortex and corticomedullary junction. To examine the cellular and subcellular pattern of
Specifically, in the CP-treated group, the S3 segments of AQP expression, we performed immunocytochemistry
proximal tubules showed evidence of tubular necrosis, on paraffin sections using specific polyclonal antibodies
loss of microvilli, and vacuolization, with surrounding to AQP1 and AQP2. The labeling pattern of AQP1 in
interstitial infiltration of blood cells (data not illustrated). the superficial cortex of CP-treated rats was not different
The superficial cortex, however, appeared to be free from the control group (data not illustrated). However,
from such alterations (data not illustrated). Additionally, in the deep cortex and corticomedullary junction, consis-
tent alterations in the labeling pattern of AQP1, espe-no histologic alterations could be detected in either the
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eral domains. Figure 6D shows that administration of
CP caused loss of microvilli and tubular architecture and
cell necrosis in S3 segment and distal part of proximal
tubules. No consistent alterations in the labeling pattern
of AQP1 were observed in outer medulla. No alterations
in the immunohistochemical labeling pattern and inten-
sity of AQP2 staining were observed in the cortex or
outer medulla of CP-treated rats as compared with the
controls. However, consistent alterations were observed
in the immunohistochemical labeling pattern of AQP2
in the inner medulla of CP-treated rats. As illustrated
in Figure 6E, intense AQP2 labeling is evident in the
apical domains (apical plasma membrane and subapical
vesicles) in nearly all of the profiles of the inner medul-
lary collecting ducts (IMCDs) of control rats. CP treat-
ment resulted in a loss of uniformity in both the pattern
and intensity of AQP2 immunolabeling. As shown in
Figure 6F, a subset of IMCD profiles showed low levels
of AQP2 labeling restricted to the apical membrane.
However, other IMCD profiles showed relatively more
AQP2 immunoreaction, although the staining was less
intense than that seen in the controls and was limited to
the apical membrane (Fig. 6G). However, in a few IMCD
profiles, more intense labeling of AQP2 protein could
be seen (Fig. 6G). Thus, CP treatment resulted in a
distributional heterogeneity of AQP2 immunoreactivity
with most of the IMCD expressing very low to moderate
levels of AQP2, which is limited to the apical membrane.
DISCUSSION
The purpose of this study was to test the hypothesis
Fig. 3. Representative immunoblots of AQP3 water channel in cortex that late-phase polyuria associated with the administra-and outer and inner medullae of saline treated (controls) and CP-
tion of the nephrotoxic anticancer drug CP is due, attreated rats. Quantities of 10, 5, and 3 mg of total protein were loaded
in each lane of the gel for cortex and outer and inner medullae, respec- least in part, to decreased expression of renal AQPs,
tively. Blots were probed with AQP3 antibody (L178) at an IgG concen- specifically AQP1, AQP2, and AQP3. Our experimentaltration of 0.03 mg/mL. Blots were exposed to longer duration to visualize
model in which rats were administered a nonlethal neph-the band from all the lanes.
rotoxic dose of CP produced the expected toxic syn-
drome, including late polyuria. Using different technical
approaches, our results support our hypothesis by dem-
cially in the proximal straight (S3) segment, as compared onstrating a significant decrease in the expression of col-
with the controls, were observed. In the control rats, lecting duct water channels (AQP2 and AQP3) as well
the proximal nephron segments in the deep cortex and as the proximal nephron water channel (AQP1) in inner
corticomedullary junction were uniformly labeled for medulla. To the best of our knowledge, this is the first
AQP1 protein and were structurally intact (Fig. 6A). In report documenting significant alterations of renal AQPs
CP-treated rats, this uniformity in labeling was conspicu- in CP-induced polyuria.
ously absent and was associated with a loss of structural In our model, the CP-treated rats lost a considerable
integrity of the proximal nephrons (Fig. 6B). Examina- degree of body weight and were afflicted with a severe
tion of the distal part of the proximal tubule at higher fall in GFR, as assessed by BUN. These changes in renal
magnification showed further consistent differences be- function are also associated with a severe degree of poly-
tween the controls and CP-treated rats, especially in the uria and loss of urinary concentrating ability. In this
S3 segment. Figure 6C shows that in control rats, the context, one can argue that the disturbances in food
architecture of the distal part of the proximal tubule and and/or water intake associated with CP administration
S3 segment was well preserved and that these structures per se can affect the urinary concentrating ability. How-
ever, substantial data exist in the literature demonstra-labeled for AQP1 protein both on the apical and basolat-
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Fig. 4. Quantitative changes in AQP1, AQP2,
and AQP3 water channel protein expression
in cortex (A), outer medulla (B), and inner
medulla (C) in CP-treated rats as determined
by densitometry of Western blots. Values are
expressed as percentage changes (mean 6 SE)
of CP-treated rats relative to the mean for the
saline-treated controls (N 5 4 for all bars).
Symbols are: ( ) native; ( ) glycosylated;
(j) total.
ting that the renal concentrating defect seen in rats ex- In our model, the changes in renal function are also
associated with high levels of platinum in the kidneyposed to CP is independent of anorexic and polydipsic
effects of this drug and is directly related to the effect tissue. The levels of an accumulation of platinum in the
cortex and outer medulla were very similar, and we ob-of CP on the kidney. Using pair-fed and/or pair-watered
control rats, at least three different groups of investiga- served a strong correlation between the platinum levels
in the cortex and outer medulla. Our immunoblottingtors have demonstrated that the urinary concentrating
defect observed after CP treatment can be dissociated experiments using peptide-derived antibodies specific to
AQP1, AQP2, and AQP3 revealed significant to modestfrom the associated changes in food and water intake
[19, 21, 30]. Thus, we can confidently exclude the possibil- alterations in the expression levels of these proteins.
Thus, the vasopressin-regulated apical AQP2 waterity that disturbances in food and/or water intake associ-
ated with CP administration may contribute to our ob- channel protein of the collecting ducts was markedly
(33% of control values) decreased in inner medulla, ac-served results.
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dulla in CP-treated rats was also associated with a marked
and matching decrease in AQP2 mRNA expression (33%
of control values), indicating that alterations in AQP2
protein expression are related to alterations in gene ex-
pression. This evidence for the altered gene regulation
is also strengthened by the fact that in our study, we did
not observe any structural damage in the medulla of CP-
treated rats at the light miscroscopy level. However, we
cannot exclude the possibility of ultrastructural alterations
in the medullary structures following CP treatment.
As stated earlier, the amount of water absorbed by
the collecting ducts is the determining factor for the
osmolality of the final voided urine. Since AQP3 protein,
under most conditions, is constitutively expressed on the
basolateral aspect of the collecting duct principal cells,
the expression of the vasopressin-regulated apical AQP2
protein in these cells is the rate-limiting factor in the
transepithelial water flow (assuming that the transepithe-
lial osmotic gradients are effectively maintained). In this
context, it is tempting to predict that the marked de-
crease in the expression of apical AQP2 water channel
coupled with a significant decrease in the basolateral
AQP3 in the inner medulla per se can account to a large
extent for the loss of urinary concentrating ability seen
following CP treatment.
Our study also suggests that there is a tendency for
an increase in AQP3 protein expression in the outer
medulla following CP treatment. Various experimental
models of acquired nephrogenic diabetes insipidus dem-
onstrated that the changes in the expression of collecting
Fig. 5. Quantitative representation of the changes in the expression duct water channels (AQP2 and AQP3) usually run inof AQP2 messenger RNA levels in the inner medulla of CP-treated
parallel [5]. However, recently it has been shown at leastrats relative to the saline-treated controls determined by densitometry
of Northern blots. The densitometric values for AQP2 mRNA were in two animal models, namely, the escape from vasopres-
normalized by the corresponding values for b-actin mRNA and ex- sin-induced antidiuresis [32] and diabetes mellitus (ab-pressed as percentage change (mean 6 SEM, N 5 4 for each bar).
stract; Nejsum et al, J Am Soc Nephrol 10:21A(A0109),
1999) that dissociation in the expression of AQP2 and
AQP3 can occur. In this context, our CP-induced poly-
companied by its modest decrease in outer medulla (77% uria is the third such experimental model to demonstrate
of control values) and cortex (63% of control values). that such a dissociation is possible under certain patho-
physiologic conditions. Finally, our study also reveals aAQP2 protein expression levels in the inner medulla of
CP-treated rats seen here are in the range of expression significant decrease in the expression of AQP1 protein
in the inner medulla. In this region of the kidney, AQP1of that reported in the medullary collecting ducts of
Brattleboro rats [31]. The latter genetically lack vaso- is expressed in the descending vasa recta and descending
thin limbs of the Henle’s loop, but not the collectingpressin (central diabetes insipidus) and thus suffer from
a severe urinary concentration defect. It is interesting duct segments that make up the bulk of the cell popula-
tion. Our immunocytochemical examination did not re-to note that the urine osmolality in Brattleboro rats is
typically around 300 mOsm/kg water, a value that is not veal any consistent changes in the expression of AQP1
protein in the inner medulla between the CP-treatedmuch different from the mean osmolality observed in
our CP-treated rats (408 mOsm/kg H2O). Furthermore, and control groups. We consider that this is due to the
inherent limitation of the immunocytochemical approachAQP2 expression levels in CP-treated rats are also simi-
lar to those reported in rat models of certain forms of rather than a true dissociation between the immunocyto-
chemical and Western blot data. The moderate decreaseacquired nephrogenic diabetes insipidus, such as hyper-
calcemia, and acute and chronic renal failure [5]. The observed in the AQP1 protein content in the outer me-
dulla as seen by Western blotting correlates well withdecrease in AQP2 protein expression in the inner me-
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Fig. 6. Representative immunohistochemical labeling for AQP1 (A–D) and AQP2 (E–G) on paraffin sections (5 mm thickness) of kidneys from
control and CP-treated rats. Sections were incubated with either AQP1 antibody (4835 EXT1; 0.4 mg/mL) or with AQP2 antibody (GN-762; 0.07
mg/mL). (A and B) Low-magnification (340) view of deep cortex and corticomedullary junction in a saline-treated control and a CP-treated rat,
respectively. Dark stained structures represent proximal tubular segments labeled for AQP1 protein. (C and D) High magnification (3400) view
of AQP1 labeled (dark areas) proximal tubular and S3 segments in the corticomedullary junction of a saline-treated control and a CP-treated rat,
respectively. (E–G) Higher magnification (3600) pictures showing AQP2 labeling (dark areas) in the IMCD of control (E) or CP-treated (F and G)
rat kidneys.
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